Task: Answer Verification
Input (English): Question: Does the presence of emphysema affect the systemic bioactivity of inhaled fluticasone in severe chronic obstructive pulmonary disease?
Answer: Severe COPD patients who are receiving high dose FP are susceptible to the development of systemic adverse effects, irrespective of the presence of emphysema.
Output (English): no